http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4049825-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a333e6344b62fb21a7c1ee592b165fca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| filingDate | 1976-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1977-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f79a4bd617bc12291541dbaa1d7318 |
| publicationDate | 1977-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4049825-A |
| titleOfInvention | Aminoalkylethers; composition and method of use |
| abstract | Diphenylmethoxyethylamines of the general formula II <IMAGE> in which R1 represents a fluorine, bromine or chlorine atom, R2 represents a hydrogen or fluorine atom and R3 represents a hydrogen, fluorine or chlorine atom, with the provisos that R3 is a hydrogen atom when R2 is a fluorine atom, R1 is a fluorine atom when R3 is a chlorine atom and R1 is a fluorine or bromine atom when R2 and R3 both are hydrogen atoms, and their non-toxic acid addition salts are disclosed. The compounds have dopaminergic properties and their use is indicated for treating the Parkinson syndrome. Compositions for such use are disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4482573-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4388469-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4459410-A |
| priorityDate | 1972-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.